SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-010586
Filing Date
2017-05-11
Accepted
2017-05-11 17:20:53
Documents
8
Period of Report
2017-06-30
Effectiveness Date
2017-05-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A jnp-def14a_20170630.htm DEF 14A 1395983
2 GRAPHIC g201705112107488371121.jpg GRAPHIC 4417
3 GRAPHIC g201705112107589171125.jpg GRAPHIC 45460
4 GRAPHIC g201705112107589051124.jpg GRAPHIC 5037
5 GRAPHIC g201705112107488311120.jpg GRAPHIC 4449
6 GRAPHIC g201705112107488761123.jpg GRAPHIC 5037
7 GRAPHIC g201705112107488621122.jpg GRAPHIC 3054
8 GRAPHIC g201705112107589441126.jpg GRAPHIC 66386
  Complete submission text file 0001564590-17-010586.txt   1582557
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10352 | Film No.: 17835486
SIC: 2834 Pharmaceutical Preparations